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Turbidity clearanceApolipoprotein E (apoE) plays a major role in the transport and metabolism of lipid by acting as a ligand for
low density lipoprotein-receptors. The amphipathic helical regions of its C-terminal domain are necessary for
the lipoprotein binding and assembly of nascent lipoprotein particles. Lipoproteins in the plasma are known
to possess a net negative charge, determined by both its protein and lipid components, which regulates the
metabolism of lipoproteins. The role of membrane surface charge on the interaction of apoE has not been
studied previously. Also the importance of individual amphipathic helical regions of its C-terminal domain in
binding to negatively charged lipid membrane is not addressed. In this study we have compared the
interaction of four peptide segments of apoE C-terminal domain (apoE(202–223), apoE(223–244), apoE(245–266),
and apoE(268–289)) with zwitterionic and negatively charged model membranes by employing UV–visible and
ﬂuorescence spectroscopy, circular dichroism, and native PAGE analysis. Our results show that the peptide
sequence 202–223, 245–266 and 268–289 of apoE has higher afﬁnity towards negatively charged lipid
membrane and are independently capable of forming lipoprotein particles of 17±2 nm Stokes diameter. The
results suggest that surface charge of lipoprotein regulates its metabolism possibly by modulating the
recruitment of apoE on its surface.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionHuman apoE is a 299 residue exchangeable apolipoprotein that
plays a major role in the distribution and metabolism of cholesterol
and triglycerides in human body [1]. Association of apoE with lipid
plays an important role in regulating its structure and functions [2].
ApoE is composed of two independently folded functional domains
that are linked by a protease sensitive hinge region [2]. The 22-kDa
N-terminal domain (residue 1–191), which folds into a four-helix
bundle of amphipathic α-helices, has a weak lipid binding property
and contains amino acid residues critical for binding to low density
lipoprotein-receptors (LDL-R) family [3–5]. While lipid-free apoE
does not bind with high afﬁnity to LDL-R, binding of apoE to the
phospholipid of lipoproteins induces a major conformational change
in the N-terminal domain enabling it to bind to the LDL-R [2,6]. The
10-kDa C-terminal domain (residues 201–299) contains regions that
are involved in lipid binding with high afﬁnity [7–12] and as well as
apoE self-association [7,13].
The primary sequence of exchangeable apolipoproteins is high-
lighted by the presence of variable number of 22-residue amphi-
pathic α-helical repeats, which confer the ability to bind to the
surface of lipoprotein particles [14]. These amphipathic helices are+91 172 2214 692.
ahoo.co.in (A.H. Pande).
ll rights reserved.also involved in the initiation of the assembly of lipoprotein particles
[15,16]. Secondary structure prediction of C-terminal domain of apoE
indicated that it is composed of two types of amphipathic α-helices.
Residues 202–223 and 223–266 forms class A helices while residues
268–289 forms class G⁎ helix [14]. Truncation analysis of C-terminal
domain [7–10] and studies with peptide fragments encompassing
speciﬁc regions of apoE [11,12] suggested that different helices
contribute differently to the lipid binding capabilities of apoE. The
binding of apoE to lipoprotein is believed to be initiated by its C-
terminal domain and the tight association of the C-terminal domain
with the surface of circulating lipoproteins not only retains apoE at
the particle surface, but also permits its N-terminal domain to
transit between the receptor-inactive and receptor active states [6].
Recent study has shown that C-terminal domain of apoE is a highly
efﬁcient mediator of cholesterol efﬂux from the cell and the
amphipathic helical segments of its C-terminal domain are neces-
sary for the nascent HDL assembly by initiating lipid binding
interaction [15].
All lipoprotein particles in the plasma are known to possess a net
negative charge and the surface negative charge of the lipoproteins
plays an important role in the lipoprotein remodeling and metabo-
lism [17]. The surface charge on the lipoproteins is determined by
both the protein and lipid components of the particles [18]. Intra-
venous administration of anionic lipids in the animals has been
shown to increase negative charge on lipoprotein particles and sti-
mulate reverse cholesterol transport (RCT) [19]. ApoE is known to
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charge on the interaction of apoE or its lipid binding fragments has
not been studied previously. Also the importance of individual
amphipathic helical regions of its C-terminal domain in binding to
negatively charged lipid membrane is not addressed. In this study we
have compared the binding of four synthetic 22-mer peptide
segments of apoE C-terminal domain, which constitutes the major
lipid binding regions of apoE, with zwitterionic and negatively
charged model membrane. Our results show that negative charge on
the membrane surface of vesicles is an important determinant of
membrane binding and lipoprotein complex forming capabilities of
amphipathic peptide sequence 202–223, 245–266 and 268–289 of
apoE.
2. Materials and methods
2.1. Materials
Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and dimyris-
toyl-sn-glycero-3-phosphoglycerol (DMPG) were purchased from
Avanti Polar Lipid (Alabaster, AL). Acrylamide, triﬂuoroethanol
(TFE), Triton X-100, chloroform, urea, sodium dodecyl sulphate
(SDS), sodium chloride, disodium ethylene diamine-tetraacetate
(EDTA), and protein standard markers of known Stokes diameter
were purchased from Sigma–Aldrich, Bangalore, India. Silver staining
kit was purchased from Bio-Rad, India. All other reagents used were
of analytical grade. Buffers used were prepared in double distilled
deionized water.
2.2. Peptides
The following peptides of human apoE C-terminal domain were
synthesized by USV Limited (Custom Peptide Synthesis Service,
Mumbai, India): apoE(202–223), apoE(223–244), apoE(245–266), and
apoE(268–289) (Fig. 1A). Except peptide apoE(223–244), rest of the
three peptides sequence originally contains one tryptophan (Trp)
each. In order to produce an intrinsically ﬂuorescent sequence,
original Leu229 was replaced by Trp within the apoE(223–244) peptide
sequence (marked by ⁎). In all cases the purity of the peptides was
found to be N95% by HPLC analysis and correct mass by electrospray
mass spectrometry. All four peptides were acetylated at the amino
terminus and amide-capped at the carboxyl terminus. In order to
remove the residual triﬂuoroacetic acid, which is generally present in
the trace amount in puriﬁed peptide preparations, the peptides were
subjected to several rounds of freeze-drying by ﬁrst dissolving in
0.1 N HCl (5–6 times) followed by double distilled deionized water
(2–3 times). Finally the peptides were suspended in aqueous buffer
containing 10 mM Hepes, 10 mM NaCl, 1 mM EDTA (pH 7.4) at a
concentration of 1.0–1.5 mg/ml. Actual concentration of the peptides
in buffer was determined in 8 M urea solution by measuring
absorbance at 280 nm and using an extinction coefﬁcient of
5635 cm−1 M−1. Finally the peptide solutions were aliquoted and
stored at −20 °C.
2.3. Preparation of multilamellar vesicles (MLV) and lipoprotein
complexes
Appropriate amounts of lipid stock solutions in chloroform were
mixed to obtain desired lipid molar ratio. The solvent was then
removed under nitrogen followed by desiccation for ~3 h. The dry
lipid ﬁlm was then hydrated by adding appropriate amount of
aqueous buffers containing either 10 mM Na, K-phosphate, (pH 7.4)
for CD measurements or 10 mM Hepes, 10 mM NaCl, 1 mM EDTA
(pH 7.4) for all other experiments, and vortexing the tubes at room
temperature to form MLV. Peptide:lipid complexes were prepared
by adding peptide solution to the measured volume of the lipid MLVto obtain the desired peptide:lipid molar ratio. The peptide:lipid
mixtures were then incubated at temperature above and below the
transition temperature of DMPC (24 °C) i.e. 10 min at 30 °C followed
by 10 min at 20 °C. After 3 heating and cooling transition cycles, the
mixtures were incubated over night at 24 °C.
2.4. Gel electrophoresis
Electrophoresis of the samples under denaturing condition
(SDS-PAGE) and nondenaturing conditions (Native PAGE) were
carried out using the method of Laemmli [25]. Electrophoresis was
carried out in a miniVE electrophoresis unit (GE Healthcare,
Uppsala, Sweden) under conditions of constant voltage. After
electrophoresis the bands were detected using Bio-Rad Silver
Stain Plus kit. The Stokes diameter of the peptide:lipid complexes
were determined from a calibration curve using the following
standards and their corresponding Stokes diameters: ovalbumin
(5.6 nm); bovine serum albumin (7.1 nm); alcohol dehydrogenase
(9.2 nm); catalase (10.4 nm); and thyroglobulin (17.2 nm).
2.5. Fluorescence quenching experiments
To study the interaction of the peptides with the lipid, we
monitored the quenching of peptides Trp ﬂuorescence by aqueous
phase quencher, acrylamide, using Perkin-Elmer LS-50B lumines-
cence spectrometer, as described previously [20]. Brieﬂy, either
peptide or peptide:lipid mixture was serially titrated with increasing
concentrations of acrylamide (4 M stock in water). The samples were
contained in a 4×4 mm2 rectangular quartz cuvette with constant
stirring. Excitation and emission slits were 4 and 10 nm, respectively.
Trp residue of the peptides was selectively excited at 290 nm and
after each addition of the quencher, emission spectra were recorded
between 300 and 400 nm. The obtained emission spectra were
corrected by subtracting the spectra measured under identical
conditions but without peptide. Maximum ﬂuorescence intensities
without and with quencher (Fo and F respectively) were determined,
and Fo/F values were plotted against the acrylamide concentrations.
The experimental data were ﬁtted with the Stern–Volmer equation
for the collisional quenching [21]:
Fo = F = 1 + KSV Q½  ð1Þ
where, [Q] is the quencher concentration and KSV is Stern–Volmer
constant for the collisional quenching process, determined from
the slope of the plot of Fo/F versus [Q]. Statistical analysis of the
data was done by t-test using SigmaStat statistical software
version 2.0.
2.6. Circular dichroism measurements
CD spectra of the peptides were recorded using a Jasco J-810
spectropolarimeter at 25 °C, as described previously [22]. To study
the effect of TFE on the structure of peptide, TFE was diluted to the
required concentrations directly into the 30 μM peptide solutions in
10 mM phosphate buffer at pH 7.4 and CD spectra were recorded. To
study the change in the structure of peptides due to their interaction
with lipid, peptide:lipid mixtures were prepared in 10 mM phos-
phate buffer at pH 7.4, as described above, and CD spectra were
recorded. The concentration of the peptide in the mixture taken for
CD analysis was 30 μM. The CD spectra were recorded using a 1 mm
path length rectangular quartz cell and following parameters were
used: 100 mdeg sensitivity, 0.5 data pitch, 50 nm/min scan speed, 1 s
response time, and 1 nm spectral bandwidth. Five scans were
averaged between 250 nm and 190 nm and corrected for the back-
ground signal by subtracting the spectra of the appropriate control
samples without peptide.
Fig. 1. (A) Amino acid sequence of the C-terminal domain (residues 201–299) of human apoE. Four 22-mer peptides used in this study are underlined. In order to produce an
intrinsically ﬂuorescent sequence, Leu229 was replaced by Trp (marked by ⁎) within the apoE(223–244) peptide sequence. (B) Helical wheel representation of four peptides. Solid line
denotes the interface between the apolar face (hydrophobic amino acids are outlined in squares) and the polar face. One-letter codes are used for the amino acid residues. The ﬁgure
was prepared using PEEPWHEEL program (http://bips.u-strasbg.fr/EMBOSS/).
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calculated as [θ]= θmeas / cnresl, where, θmeas is the measured
ellipticity in millidegrees, c is the molar concentration of the peptide,
nres is the number of amino acid residues in the peptide, and l is the
optical pathlength in millimeter.
The following equations were used to quantitate the percent α-
helicity of the peptide using mean residue molar ellipticity at 222 nm,
([θ]222), [23]:
kα − helicity = 100 × θ½ 222 =max θ½ 222
  ð2Þ
max θ½ 222 = − 40;000 1− 2:5 = nð Þ ð3Þ
where, n is the number of amino acid residues present in the peptide.2.7. Phospholipid vesicles turbidity clearance assay
Apolipoprotein or their fragment have the ability to transform
phospholipid vesicles into protein–lipid discoidal complex and this
process, which results in signiﬁcant reduction in the size of the
particles, can be monitored spectrophotometrically [24]. For the
phospholipid vesicles turbidity clearance assay lipid membranes
made up of either DMPC or 50% DMPC and 50% DMPG were made as
described above. (We have used lipid vesicle membranes made up of
50% DMPC and 50% DMPG instead of 100% DMPG in this clearance
assay because the turbidity at 325 nm of the later was very less to
measure the clearance accurately). To monitor the phospholipid
vesicles clearance, decrease in the turbidity of lipid vesicles sus-
pension was monitored at 325 nm using Perkin-Elmer UV–Visible
Fig. 2. Electrophoresis of synthetic peptides. Seven to 10 μg of individual peptides was
loaded in each lane and after electrophoresis the bands were visualized by staining
the gel with silver stain kit. (A) SDS-PAGE (20%) of peptides. Lane 1 shows the
puriﬁed recombinant C-terminal domain of apoE with the expected molecular mass
of 13,343 Da [13]. Lane 2, apoE(268–289); lane 3, apoE(245–266); lane 4, apoE(223–244);
and lane 5, apoE(202–223). (B) Nondenaturing PAGE (6%) of 0.75 mg/ml peptides; lane
6, apoE(268–289); lane 7, apoE(245–266); lane 8, apoE(223–244); and lane 9, apoE(202–223).
Lane 10 shows the mobility of puriﬁed recombinant C-terminal domain used as a
marker. Several oligomeric bands of C-terminal domain are shown by arrows.
Fig. 3. CD spectra of apoE(202–223) (panel A), apoE(223–244) (panel B), apoE(245–266)
(panel C), and apoE(268–289) (panel D) in absence and presence of increasing
concentrations of TFE. The concentration of peptide was 30 μM. The experimental
spectra were corrected by subtracting the spectra of corresponding background media
without the peptide and then converted to obtain mean residue molar ellipticities. The
concentration of TFE (v/v) used were: 0%, (black); 10%, (red); 20%, (orange); 30%,
(pink); 40%, (blue); and 50%, (green).
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(HETO CBN 8–30) and a temperature controller. The temperature of
the cuvette holder was maintained at 24 °C and all solutions were
preincubated at 24 °C before the assay. Appropriate amount of
peptide was added from the stock solution to 200 μM of lipid vesicle
membranes in 10 mM Hepes, 10 mM NaCl, 1 mM EDTA (pH 7.4),
contained in 1-cm pathlength quartz cuvette and maintained at
24 °C, to obtain a peptide:lipid molar ratio of 1:1 in case of
zwitterionic (DMPC) lipid vesicles and 1:10 in case of negatively
charged lipid vesicles made up of 50% DMPC and 50% DMPG. The
contents were mixed within 10 s by repeated pipetting and the
kinetics of peptide–lipid association was followed by monitoring the
rate of clearance at 325 nm as a function of time. Experiments were
repeated twice or thrice and average values are reported. To correct
the slight differences in the initial absorbance for each time course the
y-axis of the graph is reported as relative absorbance at 325 nmwhich
was obtained by taking the ratio of the absorbance at any given time
point to the initial absorbance at time zero. Clearance data was then
ﬁtted with monoexponential equation [24]:
Y = a  e−bx + Yo ð4Þ
where, Y is the absorbance at 325 nm, a is the change in turbidity
(pool size), b is the rate constant, x is time and Yo is the remaining
turbidity at the completion of the reaction time.
3. Results
The C-terminal domain of apoE contains amphipathic α-helical
segments, located between residue 201 and 299, which differen-
tially contributes to the lipid binding capabilities of apoE. We have
studied the effect of membrane surface charge on the lipid binding
and lipoprotein complex forming properties of 22-mer amphipathic
α-helical segments of apoE C-terminal domain by monitoring the
interaction of the peptides with zwitterionic and negatively charged
model membranes. Zwitterionic model membrane was made up of
100% DMPC while negatively charged model membranes were made
up of either 100% DMPG or 50% DMPC and 50% DMPG. Although not
physiological, DMPG is been used as an important tool in under-
standing the mechanism of interaction of peptides or proteins with
lipid by varying surface charge in the model membrane systems
[20,39–43]. Also the phase transition properties (transition tempe-
rature and enthalpy) of phosphatidylglycerol containing lipids werefound to be very similar to those of phosphatidylcholine containing
lipids [26].
3.1. Helical wheel representation of peptides
Four 22-merpeptides fromC-terminal domain of apoE: (apoE(202–223),
apoE(223–244), apoE(245–266), and apoE(268–289)), which encompass
~90% of entire apoE C-terminal domain, (Fig. 1A) were synthesized.
The helical wheel representation (Fig. 1B) of the peptides shows
that all four peptides have propensity to form α-helical structure
mimicking the general features of the amphipathic helices of
apolipoprotein [14]. The cluster of positively charged and polar
but uncharged residues marks the polar–apolar interface of all
peptides. The surface area of the apolar phase of the peptide
apoE(223–244) was narrowest in comparison to other three peptides.
Class A amphipathic helices are known to have a wide polar face
separated by apolar face and contain clusters of positively charged
residues at polar/apolar interface and a cluster of negatively
charged residues at the center of the polar face [14].
3.2. SDS- and native PAGE analysis of peptides
In aqueous solution class A amphipathic helices are known to self-
associates and forms aggregates. Self-association of the peptide was
analyzed by monitoring their mobility under denaturing and
nondenaturing conditions. SDS-PAGE and native PAGE analysis of
the peptides was carried out and the results are given in Fig. 2. On SDS
gel individual peptides moved as a single band signiﬁcantly lower that
the recombinant C-terminal domain of apoE. (A pET vector
Fig. 4. Plot of (A)α-helical percentage and (B) [θ]222/[θ]208 ratio of peptides in presence
of increasing concentrations of TFE. Experiments were performed as described in the
legend to Fig. 3. Alpha-helical percentage of apoE(202–223) (●); apoE(223–244) (▴);
apoE(245–266) (▪) and apoE(268–289) (O) was calculated on the basis of [θ]222 by using the
Eqs.(2) and (3). Symbols in panel B: apoE(202–223) (○); apoE(223–244) (Δ); apoE(245–266)
(□) and apoE(268–289) (◊). Each value is derived from two independent measurements
and the SD in the estimate was 2.0–6.2%.
Fig. 5. Representative Stern–Volmer plots showing the tryptophan ﬂuorescence
quenching of apoE(202–223) (A, B) and apoE(268–289) (C, D) peptide:lipid mixtures by
acrylamide. Peptide:DMPC (A, C) or peptide:DMPG (B, D) mixture at following peptide:
lipid molar ratio were used: (+), 1:0; (●), 1:5; (▴), 1:25; (▪), 1:50 and (O), 1:100. The
solid lines are linear regressions of the experimental data (symbols) and the slopes of
the lines give the Stern–Volmer quenching constants (KSV).
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and bearing a 17 residue N-terminal extension was a kind gift from
Vasanthy Narayanaswami, Children's Hospital Oakland Research
Institute, Oakland, California [13]. The protein was expressed and
puriﬁed to near homogeneity and used as a marker in electrophoresis
analysis. The expected molecular mass of this puriﬁed CT domain is
13,343 Da.). However, no bands were visible when the electrophoresis
was carried out under nondenaturing conditions using same amount
of peptides. Under similar conditions puriﬁed CT domain, used as a
marker protein, showed several bands of oligomeric forms (arrows).
These results indicate that synthetic peptides used in this study do not
self-associate to form aggregates. Helical wheel analysis of the pep-
tides also suggests that all of these peptides possess smaller hydro-
phobic faces which probably limit their self-association. In earlier
reports [11,12] synthetic peptide sequences apoE 202–243, apoE 211–
243, apoE 263–286 and apoE 267–286 were found to be unstructured
(and monomeric) in aqueous solutions.
3.3. CD studies of peptides in presence of TFE
Alpha-helical structure forming potential of the synthesized
peptides was also tested by treating the peptides with α-helix
inducing agent, TFE. Individual peptide was treated with increasing
concentrations (v/v) of TFE in buffer and the secondary structure
was analyzed by CD analysis. In absence of TFE, all peptides exhi-
bited the spectra with a single negative band at ~200 nm,
suggesting that all peptides exist in an unfolded state (random
coil structure) in aqueous solution [27]. Incubation of individual
peptide with increasing concentration of TFE gradually induces α-
helical structure in the peptides resulting in the spectra character-
ized by two negative bands, one at ~222 nm and another ~208 nm,
and a positive band ~195 nm. A general tendency to adopt α-helical
conformation with increasing concentrations of TFE was observed
with all four peptides (Fig. 3). TFE is known to stabilize the folding
of peptides sequences with an intrinsic propensity to adopt an α-helical structure [28]. Mean residue molar ellipticity at 222 nm,
[θ]222, was used to calculate the percentage α-helicity of peptides in
absence and presence of increasing concentrations of TFE (Fig. 4A).
The residual α-helical contents in all four peptides in absence of TFE
was b12% which is the typical for random coil structure [27]. In all
four peptides, the percentage of α-helicity increases maximally in
presence of 30–40% TFE beyond which it appears to plateau. The
maximum percentage of α-helix contents obtained for the peptides
in presence TFE were: apoE(202–223), 56%; apoE(223–244), 71%;
apoE(245–266), 46%; and apoE(268–289), 72%. The concentration of
TFE required for inducing 50% of maximal α-helicity in all four
peptides was found to be nearly same. These results indicate that all
four peptide possesses nearly similar potential to form an amphi-
pathic α-helical structure in presence of TFE.
The ratio of the magnitudes of the 222 and 208 nm minima,
[θ]222/[θ]208, in the CD spectrum of α-helical proteins has been
used to distinguish between non-associated regular helices (ratio
between 0.8 and 0.9) and coiled-coil helices (ratio of ~1.0) [27].
The [θ]222/[θ]208 ratio of the peptide in presence of increasing
concentration of TFE was calculated from the CD data and plotted
as a function of concentration of TFE (Fig. 4B). As evident, increase
in the concentration of TFE increases the [θ]222/[θ]208 ratio of
peptides and the ratio increases maximally in presence of 30–40%
TFE beyond which it appears to plateau. The maximum values of
[θ]222/[θ]208 ratio of peptides observed in presence of TFE was
between 0.7 and 0.8 (apoE(202–223)=0.80; apoE(223–244)=0.72,
apoE(245–266)=0.77 and apoE(268–289)=0.70). These observations
further indicate that the peptides studied do not possess tendency
to self-associate even when they exists in α-helical conformation.
We then carried out the characterization of interaction of peptides
with zwitterionic and negatively charged model membranes.
Fig. 7. CD spectra of peptide in absence or presence of increasing concentrations of
either zwitterionic (DMPC) lipid vesicles (dotted lines) or negatively charged
(DMPG) lipid vesicles (continuous lines). Individual peptides were mixed with
lipid vesicles to give the peptide:lipid molar ratio of 1:0, (black); 1:5, (red); 1:25,
(pink); 1:50, (blue); and 1:100, (green). Peptide:lipid mixture taken for the CD
analysis contained 30 μM of peptide and the composition of the buffer was 10 mM
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Interaction of the Trp containing peptides with lipid generally
results in the partitioning of the Trp residue into the apolar region of
the lipid membrane [29]. This decreases the exposure of the Trp
residue to the aqueous phase quenchers, like acrylamide, thereby
decreasing the quenching of ﬂuorescence emission intensity. The
microenvironment of Trp residue in the individual peptides was
probed by monitoring the ﬂuorescence quenching by acrylamide. The
emission spectra of peptide in absence or presence of increasing
concentrations of either zwitterionic (DMPC) or negatively charged
(DMPG) lipid vesicles were recorded in the presence of increasing
concentrations of acrylamide. Representative Stern–Volmer plots for
quenching of apoE(202–223) and apoE(268–289) in the absence and
presence of different concentrations of lipid vesicle are shown in Fig.
5. In presence of higher concentration of zwitterionic (DMPC) lipid
vesicles (apoE(202–223):DMPC molar ratio 1:100) there was more
quenching of ﬂuorescence of apoE(202–223) by acrylamide when
compared with lower concentration of zwitterionic (DMPC) lipid
vesicles. This indicates inaccessibility of the Trp of apoE(202–223)
peptide to quencher at the higher concentration of zwitterionic
(DMPC) lipid vesicles due to its interaction with lipid. In presence of
negatively charged (DMPG) lipid vesicles quenching of ﬂuorescence
emission of both apoE(202–223) and apoE(268–289) peptides decreased
signiﬁcantly, indicating that the Trp of these peptides in the presence
of negatively charged (DMPG) lipid vesicles experienced more
shielding and become less accessible to the aqueous phase quencher,
acrylamide, compared with zwitterionic (DMPC) lipid vesicles.
The Stern–Volmer quenching constants (KSV) were calculated
from the slope of the plots of Fo/F versus [Q] and are given in Fig. 6.
The KSV values, which reﬂect the efﬁciency of ﬂuorescence quench-
ing, for the peptides in absence of lipid vesicles were 13–14 M−1,
indicative of the complete exposure of the Trp of peptides to the
acrylamide. While the KSV values for the peptide apoE(268–289)Fig. 6. Plots of KSV values as a function of different peptide:lipid molar ratio for
peptide apoE(202–223) (panel A), apoE(223–244) (panel B), apoE(245–266) (panel C), and
apoE(268–289) (panel D). Peptide:DMPC (●) and peptide:DMPG (▴) mixtures were
prepared at the given peptide:lipid molar ratio and experiment was performed as
described in Materials and methods. The estimate of error for KSV was 3–15%.
phosphate buffer, pH 7.5. ApoE(202–223) (panel A); apoE(223–244) (panel B);
apoE(245–266) (panel C) and apoE(268–289) (panel D).decreased signiﬁcantly in the presence of all concentrations of
zwitterionic (DMPC) lipid vesicle, the KSV value for the peptide
apoE(202–223) decreased maximally to 6.1 M−1 only when the
peptide:DMPC molar ratio was 1:100. The KSV values for the peptides
apoE(223–244) and apoE(245–266) in presence of different concentra-
tions of zwitterionic (DMPC) lipid vesicles remained similar to the
KSV values for the peptides in absence of lipid. In contrast, the KSV
values for the peptides apoE(202–223), apoE(245–266), and apoE(268–289)
in the presence of negatively charged (DMPG) lipid vesicles
decreased signiﬁcantly while the KSV values for the peptide
apoE(223–244) in presence of negatively charged (DMPG) lipid vesicles
remained similar to that of the peptide in absence of lipid. In order to
see whether the observed differences in the KSV values for the
peptides in presence of zwitterionic (DMPC) and negatively charged
(DMPG) lipid vesicles are statistically signiﬁcant, the KSV values at
peptide:lipid molar ratio of 1:50 was subjected to statistical analysis.
Statistically signiﬁcant difference between the KSV values for the
peptides apoE(202–223) (P=0.011) and apoE(245–266) (P=0.004) was
observed in presence of DMPC and DMPG lipid vesicles at peptide:
lipid molar ratio of 1:50. However, the KSV values of peptide
apoE(268–289), in presence of DMPC and DMPG lipid vesicle, exhibited
less signiﬁcant statistical difference (P=0.045). Taken together, the
result of this experiment suggests that apoE(202–223), apoE(245–266)
showed preferential interaction with the negative charge lipid
vesicles, compared to zwitterionic lipid vesicles, while peptide
apoE(268–289) interact with both negative charge and zwitterionic
Fig. 8. Alpha-helical percentage of the peptides in the presence of either zwitterionic
(DMPC) lipid vesicles (circles) or negatively charged (DMPG) lipid vesicles (triangles).
Experiments were performed as described in Materials and methods. Alpha-helical
percentage of apoE(202–223) (panel A); apoE(223–244) (panel B); apoE(245–266) (panel C)
and apoE(268–289) (panel D) was calculated on the basis of [θ]222 as a function of the
indicated peptide:lipid molar ratio. Theα-helical content was calculated as described in
the legend to Fig. 4 and is the mean value at 25 °C, derived from two independent
measurements and the SD in the estimate was 2–9%.
Fig. 9. Kinetics of solubilization of lipid vesicles made up of zwitterionic (DMPC) lipid
(upper panel) and negatively charged lipid vesicles made up of 50% DMPC and 50%
DMPG (lower panel). Representative time course of the MLV clariﬁcation at 24 °C is
shown for each of the peptides. Symbols: (○), lipid vesicles alone; (Δ), lipid vesicles
plus apoE(223–244); (□), lipid vesicles plus apoE(268–289); (▿), lipid vesicles plus
apoE(202–223); and (◊), lipid vesicles plus apoE(245–266). Maximum dissolution of the
lipid vesicles at a ﬁnal concentration of 1 mM Triton X-100 is shown by cross symbols.
The measured absorbance values (symbols) were ﬁtted to a monoexponential decay
equation and the ﬁt are presented as a continuous solid lines.
1372 A.H. Pande et al. / Biochimica et Biophysica Acta 1788 (2009) 1366–1376lipid vesicles resulting in the shielding of their Trp form the aqueous
phase quencher.
3.5. CD studies of peptides in presence of lipid
In order to see whether membrane surface charge modulates
interaction of peptides with membrane vesicle and induce any
secondary structural change in the peptides, individual peptide was
mixed with either zwitterionic (DMPC) lipid vesicles or negatively
charged (DMPG) lipid vesicles and the CD spectra were recorded
(Fig. 7). The spectra of individual peptides in presence increasing
concentrations of zwitterionic (DMPC) lipid vesicles were not
different from the spectra of peptides in the absence of lipid,
suggesting that the presence of zwitterionic (DMPC) lipid vesicles
did not induced any secondary structural change in the peptides.
Similarly, the spectra of peptide apoE(223–244) remained unchanged
in presence of increasing concentrations of negatively charged
(DMPG) lipid vesicles and remained similar to that in the absence
of lipid. In contrast, in presence of increasing concentrations of
negatively charged (DMPG) lipid vesicle the CD spectra of peptides
apoE(202–223), apoE(245–266), and apoE(268–289) gradually adopted the
feature of α-helical structure, i.e. characteristic two negative bands at
222 nm and 208 nm, and a positive band at 192 nm. This indicates that
peptides apoE(202–223), apoE(245–266), and apoE(268–289) speciﬁcally
binds to negatively charged (DMPG) lipid vesicles and adopts varying
degree of α-helical structure depending on the concentration of lipid.
Percentage α-helicity of the peptides in presence of different
concentrations of zwitterionic or negatively charged lipid vesicles,
calculated from their [θ]222 values, are given in Fig. 8. In presence of
zwitterionic (DMPC) lipid vesicles the α-helical content of the
peptides did not changed when compared with the α-helical contentof the respective peptides in absence of lipid. Peptides apoE(202–223),
apoE(245–266), and apoE(268–289) when individually mixed with
negatively charged (DMPG) lipid vesicles adopted varying degree of
α-helical structure and the maximum percentage of α-helix induced
in the peptides after binding to negatively charged (DMPG) lipid
vesicles was in the order: apoE(245–266)NapoE(268–289)NapoE(202–223).
It is interesting to note here that while peptide apoE(245–266) adopted a
maximum of ~60% of α-helical structure in presence of negatively
charged (DMPG) lipid vesicles, only ~42% of α-helical structure was
maximally formed by this peptide in presence of TFE (Fig. 4).
3.6. Phospholipid vesicles turbidity clearance assay
The lipid binding afﬁnity and lipoprotein forming capability of the
peptides were evaluated by performing phospholipid vesicle turbidity
clearance assay. This assaymonitors the solubilization of phospholipid
vesicles and comparisons of the reaction kinetics gives valid
information about the relative rate of interaction of the peptides
with lipid [24]. For this assay individual peptides were mixed with
either zwitterionic (DMPC) lipid vesicles or negatively charged lipid
vesiclesmade up of 50% DMPC and 50% DMPG and the clearance of the
turbidity was followed at 325 nm. The turbidity clearance traces are
given in Fig. 9.
When only lipid vesicles were incubated without peptides
(control) a slight decrease in the vesicle light scattering intensity
was observed. Mixing of individual peptides with zwitterionic
(DMPC) lipid vesicles at 1:1 molar ratio also resulted in the decrease
in the light scattering intensity which was similar to that of control.
Under similar conditions 1 mM of Triton X-100 solubilizes the zwit-
terionic (DMPC) lipid vesicles maximally (Fig. 9, upper panel). This
suggests that none of the four peptides were able to forms
lipoprotein particles by solubilizing zwitterionic (DMPC) membrane
Table 1
Kinetic parameter describes the turbidity clearance of negatively charged lipid vesicles
made up of 50% DMPC and 50% DMPG by peptides.
Peptides Rate constant
(min−1)
Pool size
(fraction)
Fluxa
(10−2 fraction min−1)
apoE(202–223) 0.15±0.01 0.27±0.10 4.4±1.50
apoE(223–244) N.D. N.D. N.D.
apoE(245–266) 0.16±0.02 0.27±0.05 4.6±1.21
apoE(268–289) 0.11±0.03 0.23±0.04 2.9±0.88
Kinetic parameters were derived from ﬁtting experimental time courses to the
monoexponential decay equation and the best ﬁt was judged by high R2 values in all
cases (N0.99). N=3 for all the peptides and the values are reported as Mean±S.E.
N.D. refers to no detectable clearance.
a Values of product (rate constant×pool size) for each time course.
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even after 24 h of incubation of individual peptides with varying
concentrations of zwitterionic lipid vesicles (up to the peptide:
DMPC molar ratio of 1:100) (data not shown). When peptides were
mixed with negatively charged lipid vesicles made up of 50% DMPC
and 50% DMPG at 1:10 molar ratio, apoE(202–223), apoE(245–266), and
apoE(268–289) peptides showed signiﬁcant clearance of turbidity
(Fig. 9, lower panel). Peptide apoE(223–244) failed to clear the
turbidity of negatively charged lipid vesicles made up of 50% DMPC
and 50% DMPG. Maximum dissolution of negatively charged lipid
vesicles made up of 50% DMPC and 50% DMPG was achieved by the
addition of Triton X-100 to a ﬁnal concentration of 1 mM. The
traces of clearance by apoE(202–223), apoE(245–266), and apoE(268–289)
peptides were ﬁtted to monoexponential rate equation (Eq. (4)), by
nonlinear regression using Sigma Plot 2000, and the kinetic
parameters obtained are given in Table 1. Traces of the turbidity
clearance of apoE(202–223), apoE(245–266) and apoE(268–289) peptides
were best characterized by monophasic kinetics (R2N0.99). Exam-
ination of the rate constants showed very similar values for the
three peptides; the half time of the clearance of negatively charged
lipid vesicles ranged from 4.3 for apoE(245–266) to 6.3 min for
apoE(268–289). The halftime was calculated as ln2/rate constant
[24]. The pool size is the extrapolation of the 30 min data to an
equilibrium state representing the ﬁnal fraction of the initial
turbidity remaining [24]. The size of the pool for all three peptides
was found to be nearly similar. However, reaction ﬂux, obtained by
multiplying the corresponding pool size and rate constant, for the
peptides apoE(202–223) and apoE(245–266) was almost similar but was
greater than apoE(268–289) peptide.
It is known in the literature that DMPC alone forms stable MLVs
while as the ratio of DMPG to DMPC is increased in the MLVs the
stability of such MLVs decreases [32]. In order to see the difference in
the stability of MLV made up of DMPC and 50% DMPC and 50% DMPG,
MLV were treated with increasing concentration of Triton X-100 and
the turbidity clearance was monitored. It was observed that comparedFig. 10.Native PAGE analysis of peptide:DMPGmixtures. Peptide:DMPGmixture containing a
were visualized by staining the gel with silver stain kit. The Stokes diameters of the lipoprote
Peptide:DMPG molar ratio used were: lane A, 1:0; lane B, 1:5, lane C, 1:25; lane D, 1:50; anto DMPC MLV low concentration of Triton X-100 was required to
maximally solubilize the MLV made up of 50% DMPC and 50% DMPG
(results not shown). These observations suggest that under similar
experimental conditions, MLVs made up of DMPC+DMPG are more
susceptible to dissolution by Triton X-100 than MLVs made up of
DMPC alone. Taken together, these results suggest that different
stability of the MLV of DMPC and DMPC+DMPG lipids could play an
important role in lipoprotein particle formation by the peptides.
3.7. Native PAGE analysis of peptide:lipid complex
Above results suggest that the peptides apoE(202–223), apoE(245–266),
and apoE(268–289) have the ability to interact with negatively charged
(DMPG) lipid vesicles and transform them to lipoprotein particles. In
order to characterize these lipoprotein particles, the lipid:peptide
mixturewas analyzed by native PAGE analysis, which is a predominant
technique used to determine the molecular size and relative homo-
geneity to lipoprotein particles. The peptides were mixed with lipid
vesicles at different molar ratio, as described under ‘Materials and
methods’ and equal amount of mixture, containing ~7.5 μg of peptide
in each lane, were subjected to native PAGE analysis. After electro-
phoresis the bands were visualized by silver staining (Fig. 10).
As evident, peptide apoE(223–244) did not formed lipoprotein
complex with negatively charged (DMPG) lipid vesicles. Also, no
lipoprotein complexes were detected when individual peptides were
mixed with increasing concentration of zwitterionic (DMPC) lipid
vesicles (up to peptide:DMPC molar ratio of 1:100, data not shown).
However, incubation of apoE(245–266) and apoE(268–289) peptides with
negatively charged (DMPG) lipid vesicles resulted in the formation of
lipoprotein complexes when the peptide:DMPGmolar ratio was N1:5.
On the other hand, apoE(202–223) formed stable lipoprotein complex
with negatively charged (DMPG) lipid vesicles when the peptide:
DMPG ratio ranged from 1:5 to 1:50. Calculation of the Stokes
diameter of the lipoprotein complexes, by comparing with the Stokes
diameter of the standard proteins, revealed the formation of
lipoprotein particles of 17±2 nm Stokes diameter as the predominant
species. These observation indicates that apoE(202–223), apoE(245–266),
and apoE(268–289) preferentially interacts with negatively charged
lipid vesicles and forms a lipoprotein complexes of 17±2 nm Stokes
diameter. It is interesting to note here that full length apoE and its N-
and C-terminal domains also forms discoidal lipoprotein complexes of
15–20 nm Stokes diameters [30,31].
4. Discussion
Apo E is an exchangeable apolipoprotein component of plasma
lipoprotein particles and interaction of apoE with lipid regulates its
structure and functions [1–5]. Although, both N- and C-terminal
domains of apoE are capable of binding to the lipid, the high-afﬁnity
lipid binding sites are located in its C-terminal domain [2]. Thesepproximately 7.5 μg of peptides was loaded in each lane. After electrophoresis the bands
in complexes were calculated from the known Stokes diameter of the standard proteins.
d lane E, 1:100.
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of apoE with lipoproteins. To see the effect of membrane surface
charge, in the present work, we have compared the lipid binding
and lipoprotein forming capabilities of synthetic 22-mer helical
peptide sequences of C-terminal domain of human apoE with
zwitterionic (DMPC) and negatively charged (DMPG) model
membranes.
Helical wheel representation of the peptides sequence suggested
that all four peptides have the capability to form amphipathic α-
helical structure with apolar amino acid residues cluster at one
region and positively charged and polar but uncharged residues at
the apolar–polar interface. Electrophoresis of the individual peptides
under nondenaturing condition revealed no aggregate formation by
the peptides suggesting that the peptides do not possess a tendency
to self-associate. It is interesting to note that, compared to class A
amphipathic helices, which are known to have a wide hydrophobic
faces and a strong self-associating property, all four peptides used in
this study possesses smaller hydrophobic faces (Fig. 1B), which pro-
bably limit their self-association.
Individual peptide folds intoα-helical structure in presence of TFE,
indicating that all four peptides have almost equal propensity to form
stable α-helical structure in presence of TFE. Reduced accessibility of
the Trp of peptides in presence of lipid to aqueous phase quencher, like
acrylamide, has been used as a criterion for the lipid afﬁnity of the
peptides [33]. The result of the acrylamide quenching experiment
suggested that peptides apoE(202–223) and apoE(245–266) shows higher
afﬁnity towards negatively charged lipid vesicles compared to
zwitterionic lipid vesicles. While peptide apoE(268–289) showed
binding to both zwitterionic and negatively charged lipid vesicles,
peptide apoE(223–244) was unable to bind either of lipid vesicles. Earlier
report also observed that peptide sequence apoE(263–286) can bind to
zwitterionic phospholipid while peptide sequence apoE(226–243) was
unable to bind phospholipid [11]. CD analysis of peptides in presence of
increasing concentrations of lipid suggested that in presence of
negatively charged lipid vesicles, peptides apoE(202–223), apoE(245–266),
and apoE(268–289) adapted stable α-helical structure to varying extent,
depending on the concentrations of lipid vesicles. The structure of the
peptides in presence of zwitterionic lipid vesicles was similar to the
structure of peptides in the absence of lipid (Fig. 7). This clearly indicates
that peptides apoE(202–223), apoE(245–266), and apoE(268–289) binds
preferentially to the negatively charged lipid vesicles and undergoes
conformational changes to adopt a stableα-helical structure. Interaction
of peptides with lipid is known to stabilize the folding of peptide
sequences with an intrinsic propensity to adopt an α-helical structure
[28]. Upon lipid binding change in the conformation of protein or
peptide, from random coil to α-helix, provides the energetic source to
drive the lipid association of apolipoproteins [34].
The lipid binding and lipoprotein particle forming abilities of
peptides were also studied by monitoring the clearance of the lipid
vesicles to small lipoprotein particles. Out of the four peptides
apoE(202–223), apoE(245–266), and apoE(268–289) were able to clear the
negatively charged lipid vesiclesmadeup of 50%DMPGand50%DMPC.
None of the four peptides were able to solubilize the zwitterionic lipid
vesicles (Fig. 9). The kinetics of the interaction of these peptides with
negatively charged vesicles made up of 50% DMPG and 50% DMPC
resembles that of the rapid phase kinetics of association of full length
apoE isoformswith DMPC vesicles [24]. Native PAGE analysis indicated
that peptides apoE(202–223), apoE(245–266), and apoE(268–289) forms
lipoprotein particles of 17±2 nm Stokes diameter as themajor species
when mixed with negatively charged lipid vesicles (Fig. 10), while no
lipoprotein particles were detected when the peptides were mixed
with zwitterionic lipid vesicles (data not shown). In presence of lipid,
formation of the discoidal-type lipoprotein complexes of Stokes
diameter 15–20 nm seems to be a general property exhibited by full
length apoE [30] and its fragments [31] and also by other classes of
lipoproteins [35,36].The formation of discoidal-type lipoprotein particles with
phospholipid was explained on the basis of shielding of the
hydrophobic face on the amphipathic helix of the peptide at the
edge of the lipid bilayer. Relative area of the polar and apolar faces
in the amphipathic helices are known to inﬂuence the lipid binding
properties of the peptides [37]. ApoE(223–244) peptide showed the
narrowest apolar face as compared to the other three peptides in
the helical wheel representation (Fig. 1B). Probably this feature
makes apoE(223–244) peptide too hydrophilic to bind to phospholi-
pids. This observation is in agreement with the earlier study [11]
which reported that the peptide sequence apoE(226–243), which
carried the original Leu229 and which is very similar to the peptide
apoE(223–244) used in this study, was too hydrophilic to bind
phospholipid.
It is interesting to note here that lipid binding by amphipathic
helical peptides of apolipoproteins do not always results in the
formation of lipoprotein particles. At peptide:DMPG molar ratio 1:5,
the peptide apoE(245–266) did not formed any detectable lipoprotein
particles, as evident from the lack of lipoprotein band in the native
PAGE gel (Fig. 10) even though it has bound to the lipid, as evident by
decrease in KSV values for acrylamide (Fig. 6), and has adapted α-
helical structure (~23% more α-helical structure than peptide in
absence of lipid) (Fig. 8). On the other hand, peptide apoE(202–223) has
formed homogenous stable lipoprotein particles at peptide:DMPG
molar ratio of 1:5 and has gained only ~12% of α-helical structure
more as compare to the peptide in absence of lipid. Discoidal
lipoprotein particle formation by apolipoproteins is known to be a
multi-step pathway in which amphipathic α-helices initially adsorbs
to the lipid bilayer surface resulting in the induction of the confor-
mation changes in the protein component followed by insertion into
the lipid packing defects in phospholipid surface and reorganization of
the lipid and protein components into discoidal particle [38]. It
appears that inability of the amphipathic peptide sequence to perform
any of these steps results in a failure to form lipoprotein complex.
Comparative studies of the apoE deletion mutants, truncated at
C-terminal residues 266, 244, and 191, revealed that all mutants
had reduced afﬁnity for lipoprotein [7]. Removal of the C-terminal
helical regions spanning residues 273–299 weakens the ability of
apoE isoforms to bind to lipoprotein particles [8–10]. Recent report
also provided the evidence of importance of apo E residues in the
range 250–299 in lipid binding [48]. This indicates that extreme C-
terminal parts of the apoE molecule play an important role in
binding to lipid. Our results show that sequence 202–223, 245–266
and 268–289 of apoE shows different afﬁnities towards different
lipid surfaces. ApoE is known to bind different lipoprotein particles
such as very low density lipoprotein (VLDL) and high density
lipoprotein (HDL) and forms both exchangeable and non-exchange-
able pools. The observation that peptide sequence 223–244 do not
bind lipid may suggest its role in modulating the association and
dissociation of apoE C-terminal domain to the surface of lipoprotein
particles.
Lipoprotein particles in the plasma are known to bear a net
negative charge which is determined by both the protein and the lipid
compositions of the particle [17–19]. The negative charge of the
lipoprotein particles regulate the activities of various enzymes
associated with lipoproteins and also modulate the association of
lipoproteins with cell surface proteins and plasma enzymes [17].
Intravenous administration of anionic lipids into the animal has been
shown to increase net negative charge on lipoproteins, by incorpora-
tion of administered anionic lipids into the lipoprotein, and stimulate
RCT [19]. It has been proposed that administration of anionic lipidmay
have therapeutic value to modulate lipoprotein charge in vivo and
regulate its metabolism [17].
Peroxidation of unsaturated phospholipid bearing a cis-9 double
bond generates oxidized phospholipid having carboxyl function [39].
One of the abundant oxidized phospholipid generated due to
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glycero-3-phosphocholine (PazePC), which is known to exposes its
carboxyl function of the azelaoyl chain at sn-2 position to the aqueous
phase, bears negative charge at physiological pH, and is known to
interact with cationic proteins [40].
Presence of such oxidized lipids or other anionic lipids can
preferentially initiate the lipoprotein complex formation by apoli-
poproteins as the amphipathic α-helical regions of apolipoproteins
possesses positively charged amino acid residues cluster most
frequently at the polar–apolar interface. This arrangement allows
the interaction of apolipoproteins with negatively charged lipid
more strongly than with zwitterionic lipid [41–45]. Recently, anti-
inﬂammatory properties of apoA-I mimetic peptide has been attri-
buted to their extraordinary ability to bind pro-inﬂammatory oxidized
phospholipids [46]. The peptides used in the current study also show
preferential binding to membrane containing oxidized phospholipid,
1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PazePC) [47].
Further investigation is needed to see whether these peptides also
possess anti-inﬂammatory properties.
The negative charge on the membrane surface thus acts as an
important determinant of membrane binding and lipoprotein com-
plex forming capabilities of peptide sequence 202–223, 245–266 and
268–289 of apoE. It is speculated that increased negative charge on
the lipoprotein particles, either by administration of anionic lipids or
accumulation of oxidized phospholipids having carboxyl function,
may recruits more apoE on the surface of these lipoprotein particles
resulting in the enhanced clearance by RCT.
In summary, our results suggests that individual amphipathic
helices (peptide sequence 202–223, 245–266 and 268–289) of the
C-terminal domain of apoE are not only capable of driving the
initial binding of apoE to negatively charged lipid vesicles but are
also capable of forming nascent lipoprotein particles of 17±2 nm
Stokes diameter with negatively charged lipid vesicles.
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